drugset / Trial / NCT04316806
Effect of a Probiotic Formula on Reducing SIBO in IBS Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
This randomized study evaluates the effectiveness of the a probiotic formula, compared with the antibiotic rifaximin, in the treatment of Small Intestinal Bacterial Overgrowth (SIBO) in Irritable Bowel Syndrome (IBS) patients.
Timeline
- Start
- 2020-11-20
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifaximin | Other / unclassified | 400 mg | — |